Hints and tips:
Related Special Reports
...They include the popular new diabetes and weight-loss drugs Ozempic and Wegovy, made by Novo Nordisk, and Mounjaro and Zepbound made by Eli Lilly....
...Offering “convenience” to patients was another way for new entrants to stand out, said Michael Yee, an analyst at Jefferies....
...The drugs, developed by Japanese pharma company Eisai and US company Eli Lilly, tackle the build-up of amyloid plaques in the brain that trigger the disease, rather than address symptoms like current treatments...
...In October, pharmaceuticals companies Eisai and Eli Lilly unveiled research showing the benefits of using new Alzheimer’s drugs very early in the development of the disease....
...The US list price of the drug is about $1,350 for a month’s supply, while Zepbound, a competing product from Eli Lilly, costs $1,060....
...“You are going to see more differentiation between the megacaps and arguably we already are,” said Michael Grant, head of long/short strategies at Calamos Investments....
...Dozens of multinationals manufacturers such as PepsiCo and Eli Lilly have complied with the Programme HQ edict....
...Michael Yee, analyst at Jefferies, said the strong efficacy shown by Lilly’s drug should help persuade US government officials to allow public-funded insurance policies to reimburse the new class of drugs...
...US Federal Reserve: Michael Barr, the Fed’s vice-chair for supervision, speaks at the National Interagency Community Reinvestment Conference in Portland, Oregon. Five more top stories 1....
...News round-up India’s business elite sounds alarm over Rolex thefts in London’s Mayfair (FT) Eli Lilly calls for scrutiny of rival Novo Nordisk’s $11bn deal production deal (FT) Canary Wharf office takes...
...Monetary policy: US Federal Reserve vice-chair for supervision Michael Barr will speak about bank regulation at an event in Washington....
...Additional help from Saffeya Ahmed, Monica Lopez, Katie McMurran, Peter Barber, Michael Lello, David da Silva and Gavin Kallmann. Topher Forhecz is the FT’s executive producer....
...The pair will also compete in China when Eli Lilly introduces tirzepatide for weight loss....
...Its non-tech winners included Apollo Global, Eli Lilly, Airbus and online gambling company Flutter....
...Additional help by Peter Barber, Michael Lello, David da Silva and Gavin Kallmann. Topher Forhecz is the FT’s executive producer. The FT’s global head of audio is Cheryl Brumley....
...Michael GoldbergPartnerAkerman Michael Goldberg has handled many receiverships and has honed his flair for working with the many constituents involved....
...We had help this week from Saffeya Ahmed, David da Silva, Michael Lello, Peter Barber and Gavin Kallmann. Our executive producer is Topher Forhecz....
...Michael Lohan said Ireland was poised to win several big investments from pharmaceutical and medical device companies attracted to the country’s blend of tax incentives, political stability, skilled workforce...
...Eli Lilly as well, one of their longtime rivals, is the only other company that’s kind of level pegging in obesity has also been developing these internally....
...For those of the vintage who may to want to see Michelle Pfeiffer and Michael Douglas star in a film together, the company says you can....
...Average waiting times for larger tankers carrying liquefied natural gas north through the canal increased from eight days as of July 10 to 18 days as of Thursday, according to shipping agency Norton Lilly...
...Lilly’s behaviour, he says, is “really uncool”. How do his children see him? “Papa.” And his tennis career? “They don’t care.”...
...Just last week, Eli Lilly, the producer of popular insulin medications Humalog and Humulin, pledged to reduce its insulin list prices by 70 per cent in an effort to make the medicine more affordable....
...It lowered the standards for approving drugs for Alzheimer’s disease and that’s why you see a rush of companies targeting beta amyloid in the brain,” said Michael Carome, director of health research at Public...
...BenevolentAI has helped identify Eli Lilly’s arthritis drug baricitinib, also known as Olumiant, as a Covid-19 treatment....
International Edition